← Back to Search

Bright Light Therapy for Opioid Use Disorder

N/A
Recruiting
Led By Chung Jung Chung Jung, Ph.D.
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily for the 1 week at baseline and throughout the treatment period (up to 2 weeks)
Awards & highlights

Summary

This trialstudies the effects of bright light therapy on opioid use disorder patients undergoing medication-assisted treatment.

Who is the study for?
This trial is for English-speaking adults aged 18-65 with opioid use disorder who are in outpatient treatment, have had stable medication doses for a month, and suffer from insomnia. They must own a smartphone. People with bipolar disorder, high risk of sleep apnea, eye conditions or surgeries, certain medication usage, recent night shift work or travel outside Arizona time zone can't participate.
What is being tested?
The study tests the effects of bright light therapy using wearable devices on patients' reward system functioning during opioid addiction treatment. Participants will be randomly assigned to either real bright light therapy or a placebo device without knowing which one they receive.
What are the potential side effects?
Potential side effects may include discomfort due to bright light exposure such as eye strain or headache. Since it's non-invasive and doesn't involve drugs, serious side effects are unlikely but could include mood changes if underlying conditions like bipolar disorder were undiagnosed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily for the 1 week at baseline and throughout the treatment period (up to 2 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily for the 1 week at baseline and throughout the treatment period (up to 2 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of the intervention
Changes in Opioid Craving
Changes in reward learning
+3 more
Secondary study objectives
Illicit Opioid Use Frequency
Negative Affect
Positive Affect
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Bright light therapy groupExperimental Treatment1 Intervention
Participants will receive 30-minute morning bright light therapy for 2 weeks. Participants will start the therapy within a few minutes of their designated wake up time, which is determined by their average wake time from the baseline week of sleep assessment.
Group II: Dim light (placebo) groupPlacebo Group1 Intervention
Participants will receive 30-minute dim light (placebo) therapy for 2 weeks. Participants will start the therapy within a few minutes of their designated wake up time, which is determined by their average wake time from the baseline week of sleep assessment.

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
294 Previous Clinical Trials
107,407 Total Patients Enrolled
Chung Jung Chung Jung, Ph.D.Principal InvestigatorArizona State University
Chung Jung Mun, Ph.D.Principal InvestigatorArizona State University
1 Previous Clinical Trials
20 Total Patients Enrolled
~4 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top